According to the Wall Street Journal, Mark Hayes, a lobbyist for health insurance giant Humana, confirmed news of the not-yet-public decision to Washington investment-research firm Height Securities, which alerted clients of the move before the agency publicly announced the higher rates. The raised MA payments will mean billions more for the health insurance industry, and now the Securities and Exchange Commission is looking into the situation.
Mr. Hayes was formerly a top health policy aide for Sen. Charles Grassley (R-Iowa), who has been vocally critical of the “political intelligence” industry exemplified in this case.
More Articles on Medicare Advantage:
10 Most Common Medicare Risk Adjustment Coding Errors
Budget Breakdown: How President Obama’s FY 2014 Budget Would Affect Hospitals
CMS’ Tavenner Gets Warm Response in Appointment Hearing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
